S&P 100
3.117,66
PKT
+19,01
PKT
+0,61
%
Werbung
Analysen zu S&P 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
07.05.12 | Intel buy | UBS AG | |
07.05.12 | Amazon outperform | RBC Capital Markets | |
07.05.12 | Visa outperform | RBC Capital Markets | |
07.05.12 | MasterCard outperform | RBC Capital Markets | |
07.05.12 | Linde buy | Société Générale Group S.A. (SG) | |
07.05.12 | Microsoft overweight | Barclays Capital | |
07.05.12 | United Parcel Service overweight | Barclays Capital | |
07.05.12 | Linde halten | Independent Research GmbH | |
07.05.12 | Johnson Johnson kaufen | Fuchsbriefe | |
07.05.12 | Oracle buy | Stifel, Nicolaus & Co., Inc. | |
07.05.12 | General Motors outperform | RBC Capital Markets | |
07.05.12 | General Motors buy | UBS AG | |
04.05.12 | IBM buy | Stifel, Nicolaus & Co., Inc. | |
04.05.12 | Microsoft buy | Stifel, Nicolaus & Co., Inc. | |
04.05.12 | Linde kaufen | Bankhaus Lampe KG | |
04.05.12 | Intel buy | Sarasin Research | |
04.05.12 | Cisco buy | Caris & Company, Inc. | |
04.05.12 | Linde neutral | WestLB AG | |
04.05.12 | Linde buy | Commerzbank Corp. & Markets | |
04.05.12 | Linde buy | Sarasin Research | |
04.05.12 | Linde halten | National-Bank AG | |
04.05.12 | Apple overweight | JP Morgan Chase & Co. | |
04.05.12 | MasterCard overweight | Barclays Capital | |
04.05.12 | Devon Energy overweight | Barclays Capital | |
04.05.12 | Visa strong buy | Raymond James Financial, Inc. | |
04.05.12 | Visa buy | Deutsche Bank Securities | |
03.05.12 | AT&T outperform | Oppenheimer & Co. Inc. | |
03.05.12 | Pfizer equal-weight | Barclays Capital | |
03.05.12 | CVS Health buy | UBS AG | |
03.05.12 | AT&T neutral | UBS AG | |
03.05.12 | Comcast buy | UBS AG | |
03.05.12 | Biogen overweight | Barclays Capital | |
03.05.12 | Biogen buy | Jefferies & Company Inc. | |
03.05.12 | Cisco sector perform | RBC Capital Markets | |
03.05.12 | Biogen outperform | RBC Capital Markets | |
03.05.12 | ConocoPhillips hold | Société Générale Group S.A. (SG) | |
03.05.12 | Pfizer buy | UBS AG | |
03.05.12 | Biogen overweight | Morgan Stanley | |
03.05.12 | Pfizer overweight | JP Morgan Chase & Co. | |
03.05.12 | Freeport-McMoRan buy | Jefferies & Company Inc. |